Breakthrough Therapy Designations Surge as $50B Cancer Drug Partnerships Reshape Market Biotech Investing
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics Biotech Investing
Real-World Evidence Supports Clinical Effectiveness of neffy® in Patients Experiencing Anaphylaxis Biotech Investing
Quantum-Si Announces the Launch of V4 Sequencing Kit, Expanding Proteome Coverage and Unlocking New Applications for Protein Sequencing Biotech Investing
Cocrystal Pharma Receives FDA IND Clearance for Challenge Study of Oral Broad-Spectrum Protease Inhibitor CDI-988, a Potential First Antiviral for Norovirus Prevention and Treatment Biotech Investing
BioAtla Announces Regulatory Update on Clinical Development Plan for Ozuriftamab Vedotin in Oropharyngeal Squamous Cell Carcinoma Following Productive Type B Meeting with FDA Biotech Investing
Pasithea Therapeutics Announces Enrollment of Cohort 2 following Positive Safety Review Committee Recommendation for its Ongoing Phase 1/1b Clinical Trial of PAS-004 in Adult NF1 Patients Biotech Investing
Longer-Term Follow-Up of Western Patients Showed Improving, Favorable Trend in Overall Survival in Global Phase III HARMONi Clinical Trial for Ivonescimab Plus Chemotherapy in 2L+ EGFRm NSCLC Biotech Investing
